Eagle Wealth Strategies LLC lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 26.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,954 shares of the exchange traded fund’s stock after selling 1,089 shares during the quarter. Eagle Wealth Strategies LLC’s holdings in SPDR S&P Biotech ETF were worth $266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of the company. Tidemark LLC raised its holdings in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $44,000. Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $49,000. Finally, Waldron Private Wealth LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $54,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA:XBI opened at $90.51 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The company has a market cap of $6.90 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average price is $93.58 and its 200-day moving average price is $96.95.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What is the S&P/TSX Index?
- Avient Stock: Manufacturing Play With Double-Digit Upside
- What is the Dogs of the Dow Strategy? Overview and Examples
- Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
- Business Services Stocks Investing
- Super Micro Computer: Turning Risk Into Reward at the Crossroads
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.